Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ayumu Yoshikawa
Institutions:
National Cancer Center Hospital East,
Japanese Red Cross Kitami Hospital
Observed institutions:
National Cancer Centre Japan,
National Cancer Center Hospital East,
Japanese Red Cross Kitami Hospital
ORCID:
0009-0005-3142-6164
Observed ORCID:
0009-0005-3142-6164
OpenAlex ID:
A5088790690
Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer
2022
·
Ayumu Yoshikawa
, Yoshiaki Nakamura
·
Cancers
·
21
PDF
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
·
Cancer Research Communications
·
10
PDF
[Treatment Strategies for HER2-Positive Metastatic Colorectal Cancer].
2023
·
Ayumu Yoshikawa
, Yoshiaki Nakamura
·
PubMed
·
1
Interim analysis results of gut microbiota in patients with unresectable cholangiopancreatic cancer: SCRUM-Japan MONSTAR-SCREEN.
2023
·
Shun Tezuka
, Shunsuke Sakai
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Gut microbiome features associated with PIK3CA-mutated colorectal cancer: A nationwide pan-cancer genomic and microbial profiling study (MONSTAR-SCREEN)
2026
·
Shogen Boku
, Shunsuke A. Sakai
, et al.
·
Scientific Reports
PDF
A prospective observational study of treatment sequencing with regorafenib and FTD/TPI in metastatic colorectal cancer: The OSERO study
2026
·
Takeshi Kawakami
, Toshiki Masuishi
, et al.
·
British Journal of Cancer
Supplementary Table S3 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Table S1 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S8 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Table 2 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Table S4 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S6 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Table 1 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Table S2 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Table 3 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S7 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S10 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Figure 3 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S5 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S11 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S1 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S3 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Supplementary Figure S4 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Data from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Figure 1 from Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
Show more works
View as search
Works count:
29
Citation count:
33
H-index:
2
I10-index:
2
Year
Topic
Type